CVS Health® (NYSE: CVS) announced the addition of four new members to its Board of Directors: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman. These appointments follow collaborative discussions with Glenview Capital Management.
“Our discussions with Glenview have reinforced our commitment to enhancing value for all stakeholders, including customers, colleagues, and shareholders,” said Roger Farah, Executive Chairman of the CVS Health Board. “Leslie, Larry, Guy, and Doug bring fresh perspectives and deep expertise that will support our efforts to strengthen financial and operational performance.”
David Joyner, President and CEO of CVS Health, highlighted the significance of the new appointments, stating, “These leaders will help sharpen our focus on executing our strategy to build a consumer-centered health care model, improve the total cost of care, and enhance customer experience.”
Larry Robbins, CEO of Glenview Capital Management, expressed enthusiasm about the collaboration: “We are eager to work with the Board and leadership to drive sustainable value through customer-centric innovation, compliance excellence, disciplined risk management, and strategic capital allocation.”
The new directors will serve on key committees:
- Leslie Norwalk will join the Health Services Committee.
- Guy Sansone will serve on the Audit Committee.
- Doug Shulman will join the Management Planning and Development Committee.
With these additions, CVS Health’s Board expands to 16 members. In connection with these appointments, CVS Health and Glenview have entered a confidentiality agreement, which includes customary provisions on confidentiality and standstill terms. The agreement will be filed with the U.S. Securities and Exchange Commission on Form 8-K.
